查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1936748

全球真實世界證據解決方案市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Real World Evidence Solutions Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 166 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

真實世界證據 (RWE) 解決方案市場規模預計將從 2025 年的 36.7 億美元成長到 2034 年的 79.3 億美元，2026 年至 2034 年的複合年成長率為 8.93%。

全球真實世界證據 (RWE) 解決方案市場預計將迎來顯著成長，這主要得益於醫療決策中對數據驅動型洞察日益成長的需求。 RWE 指的是從真實世界數據分析中獲得的臨床證據，這些數據包括患者健康狀況和醫療服務提供方面的資訊。隨著包括製藥公司、支付者和監管機構在內的醫療生態系統相關人員尋求更好地了解治療的有效性和安全性，RWE 解決方案的應用預計將顯著增加。此外，對基於價值的醫療保健的日益重視以及對證據支持報銷決策的需求，也進一步推動了這一趨勢。

此外，數據分析技術的進步有望徹底改變真實世界證據（RWE）解決方案領域。巨量資料、機器學習和人工智慧的融合正在提升分析大量真實世界數據的能力，並提供可操作的洞見，從而指導臨床實踐和政策制定。此外，電子健康記錄和病患登記系統的日益普及，促進了高品質資料的收集，進一步推動了對RWE解決方案的需求。隨著醫療機構認知到真實世界證據在支持其臨床和商業策略方面的價值，預計市場上將湧現出大量滿足此需求的創新解決方案。

此外，對病人參與的日益重視以及患者報告結果的重要性預計將塑造真實世界證據（RWE）解決方案市場的未來。隨著患者更多地參與到自身的醫療保健決策中，能夠捕捉患者體驗和結果的解決方案的需求也變得日益重要。融入患者觀點的RWE解決方案將有助於更全面地了解治療效果，最終改善患者照護。數據提供者、醫療保健提供者和監管機構之間的合作對於推動這一進程至關重要，並確保RWE解決方案市場始終處於實證醫學的前沿。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球真實世界證據解決方案市場（按組件分類）

  • 市場分析、洞察與預測
  • 服務
  • 資料集

5. 全球真實世界證據解決方案市場（按應用領域分類）

  • 市場分析、洞察與預測
  • 藥物研發與核准
  • 醫療設備開發與核准
  • 報銷、承保範圍和監管決策
  • 上市後安全性與不利事件監測

6. 全球真實世界證據解決方案市場（按最終用途分類）

  • 市場分析、洞察與預測
  • 醫療相關企業（製藥、生物製藥、醫療設備）
  • 醫療保險公司
  • 醫療保健提供者
  • 其他

7. 全球真實世界證據解決方案市場（按治療領域分類）

  • 市場分析、洞察與預測
  • 腫瘤學
  • 心臟病學
  • 神經病學
  • 糖尿病
  • 精神病學
  • 呼吸系統
  • 其他

8. 全球真實世界證據解決方案市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • IQVIA Inc
    • IBM
    • PPD Inc.（Acquired By Thermo Fisher Scientific Inc.）
    • Parexel International（MA）Corporation
    • PerkinElmer Inc
    • ICON Plc
    • Oracle
    • Syneos Health
    • Cegedim Health Data
    • Medpace
簡介目錄
Product Code: VMR11212359

The Real World Evidence Solutions Market size is expected to reach USD 7.93 Billion in 2034 from USD 3.67 Billion (2025) growing at a CAGR of 8.93% during 2026-2034.

The global real-world evidence (RWE) solutions market is set to witness substantial growth, driven by the increasing demand for data-driven insights in healthcare decision-making. RWE refers to the clinical evidence derived from the analysis of real-world data, which includes information on patient health status and the delivery of healthcare. As stakeholders in the healthcare ecosystem, including pharmaceutical companies, payers, and regulatory agencies, seek to enhance the understanding of treatment effectiveness and safety, the adoption of RWE solutions is expected to rise significantly. This trend is further supported by the growing emphasis on value-based care and the need for evidence to inform reimbursement decisions.

Moreover, advancements in data analytics and technology are anticipated to transform the RWE solutions landscape. The integration of big data, machine learning, and artificial intelligence is enhancing the ability to analyze vast amounts of real-world data, providing actionable insights that can inform clinical practice and policy. Additionally, the increasing availability of electronic health records and patient registries is facilitating the collection of high-quality data, further driving the demand for RWE solutions. As healthcare organizations increasingly recognize the value of real-world evidence in supporting clinical and commercial strategies, the market is likely to witness a surge in innovative solutions that cater to these needs.

In addition, the growing focus on patient engagement and the importance of patient-reported outcomes are expected to shape the future of the RWE solutions market. As patients become more involved in their healthcare decisions, the need for solutions that capture their experiences and outcomes is becoming increasingly important. RWE solutions that incorporate patient perspectives can provide a more comprehensive understanding of treatment impact, ultimately leading to improved patient care. Collaborative efforts between data providers, healthcare organizations, and regulatory bodies will be essential in driving these advancements, ensuring that the RWE solutions market remains at the forefront of evidence-based healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

  • Services
  • Data Sets

By Application

  • Drug Development & Approvals
  • Medical Device Development & Approvals
  • Reimbursement/Coverage and Regulatory Decision Making
  • Post Market Safety & Adverse Events Monitoring

By End-use

  • Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device)
  • Healthcare Payers
  • Healthcare Providers
  • Others

By Therapeutic Area

  • Oncology
  • Cardiology
  • Neurology
  • Diabetes
  • Psychiatry
  • Respiratory
  • Others

COMPANIES PROFILED

  • IQVIA Inc, IBM, PPD Inc acquired by Thermo Fisher Scientific Inc, Parexel International MA Corporation, PerkinElmer Inc, ICON plc, Oracle, Syneos Health, Cegedim Health Data, Medpace

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Data Sets Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Drug Development & Approvals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Medical Device Development & Approvals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Reimbursement/Coverage and Regulatory Decision Making Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Post Market Safety & Adverse Events Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Healthcare Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Healthcare Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Therapeutic Area
  • 7.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Psychiatry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.7. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Component
    • 8.2.2 By Application
    • 8.2.3 By End-use
    • 8.2.4 By Therapeutic Area
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Component
    • 8.3.2 By Application
    • 8.3.3 By End-use
    • 8.3.4 By Therapeutic Area
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Component
    • 8.4.2 By Application
    • 8.4.3 By End-use
    • 8.4.4 By Therapeutic Area
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Component
    • 8.5.2 By Application
    • 8.5.3 By End-use
    • 8.5.4 By Therapeutic Area
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Component
    • 8.6.2 By Application
    • 8.6.3 By End-use
    • 8.6.4 By Therapeutic Area
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL REAL WORLD EVIDENCE SOLUTIONS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 IQVIA Inc
    • 10.2.2 IBM
    • 10.2.3 PPD Inc. (Acquired By Thermo Fisher Scientific Inc.)
    • 10.2.4 Parexel International (MA) Corporation
    • 10.2.5 PerkinElmer Inc
    • 10.2.6 ICON Plc
    • 10.2.7 Oracle
    • 10.2.8 Syneos Health
    • 10.2.9 Cegedim Health Data
    • 10.2.10 Medpace